Baxter International Inc (BAX) SEC filings

BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/304% above fair value

$25.81+0.07 (+0.27%)

Close on Nov 13, 2026Market cap $13.35BP/E –Yield 2.01%

SEC filings

40 of Baxter International's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Oct 29, 2026	SEC EDGAR
Current report	8-K	Oct 28, 2026	Oct 29, 2026	SEC EDGAR
Current report	8-K	Aug 18, 2026	Aug 19, 2026	SEC EDGAR
Current report	8-K	Aug 18, 2026	Aug 18, 2026	SEC EDGAR
Current report	8-K	Aug 4, 2026	Aug 4, 2026	SEC EDGAR
Current report	8-K	Jul 31, 2026	Aug 4, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Jul 30, 2026	SEC EDGAR
Current report	8-K	Jul 29, 2026	Jul 30, 2026	SEC EDGAR
Current report	8-K	Jul 14, 2026	Jul 14, 2026	SEC EDGAR
Current report	8-K	May 4, 2026	May 8, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	Apr 30, 2026	SEC EDGAR
Current report	8-K	Apr 29, 2026	Apr 30, 2026	SEC EDGAR
Proxy statement	DEF 14A	May 5, 2026	Mar 23, 2026	SEC EDGAR
Current report	8-K	Mar 19, 2026	Mar 19, 2026	SEC EDGAR
Current report	8-K	Mar 15, 2026	Mar 16, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Feb 12, 2026	SEC EDGAR
Current report	8-K	Feb 10, 2026	Feb 12, 2026	SEC EDGAR
Current report	8-K	Dec 22, 2025	Dec 22, 2025	SEC EDGAR
Current report	8-K	Dec 4, 2025	Dec 4, 2025	SEC EDGAR
Current report	8-K	Nov 25, 2025	Nov 25, 2025	SEC EDGAR
Current report	8-K	Nov 19, 2025	Nov 19, 2025	SEC EDGAR
Current report	8-K	Nov 19, 2025	Nov 19, 2025	SEC EDGAR
Current report	8-K	Nov 5, 2025	Nov 12, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 4, 2025	SEC EDGAR
Current report	8-K	Oct 30, 2025	Oct 30, 2025	SEC EDGAR
Current report	8-K	Oct 16, 2025	Oct 21, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 5, 2025	SEC EDGAR
Current report	8-K	Jul 31, 2025	Jul 31, 2025	SEC EDGAR
Current report	8-K	Jul 7, 2025	Jul 7, 2025	SEC EDGAR
Current report	8-K	Jun 11, 2025	Jun 12, 2025	SEC EDGAR
Current report	8-K	May 6, 2025	May 8, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 6, 2025	SEC EDGAR
Current report	8-K	May 1, 2025	May 1, 2025	SEC EDGAR
Proxy statement	DEF 14A	May 6, 2025	Mar 25, 2025	SEC EDGAR
Current report	8-K	Mar 14, 2025	Mar 14, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Feb 21, 2025	SEC EDGAR
Current report	8-K	Feb 20, 2025	Feb 20, 2025	SEC EDGAR
Current report	8-K	Jan 31, 2025	Feb 3, 2025	SEC EDGAR
Current report	8-K	Feb 1, 2025	Feb 3, 2025	SEC EDGAR
Current report	8-K	Jan 31, 2025	Jan 31, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Baxter International's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on May 31, 2001
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BAX.

Compare: BAX vs SOLV · BAX vs BDX · BAX vs BSX · BAX vs RMD · BAX vs TFX

Revenue growth5.3% · median 9.0%

Gross margin30.1% · median 58.3%

Operating margin-1.9% · median 10.7%

Net margin-6.2% · median 8.8%

Company	Revenue	Growth
BDX	$23.25B	+17.4%
BSX	$21.07B	+8.9%
BAX	$11.61B	+5.3%
SOLV	$8.16B	-2.8%
RMD	$5.73B	+9.0%
TFX	$2.26B	+20.9%

Company

Next earnings (est.): Feb 11, 2027, before open
Exchange: NYSE
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 37,500
Held by institutions: 100.0%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 10456

Advertisement
300 × 250

See a number that looks wrong?